pdf
Published
2019-11-19
Issue
Section
Analytical Essays
License
Copyright (c) 2019 Natalie Bontrager
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Public Health Review are distributed with a Creative Commons Noncommercial Attribution license (CC BY-NC 4.0). This means that each author holds the copyright to their work, and grants users the rights to: share (copy and/or redistribute the material in any medium or format) or adapt (remix, transform, and/or build upon the material) the article, as long as the original author and source are cited, and the use is for noncommercial purposes. Permission is not needed for these noncommercial uses. Read the summary terms, or the full legal license code.
Wolbachia Infections and Their Impact on Outbreaks of Yellow Fever Virus
Natalie Bontrager
University of Minnesota School of Public Health
Abstract
Yellow Fever Virus is responsible for 30,000 human deaths annually in the equatorial regions of Africa and South America. Due to frequent urban outbreaks and a shortage of Yellow Fever vaccines new control measures are necessary to protect the health of humans. This paper is a review of current research regarding the potential use of Wolbachia bacteria as a biocontrol for the largest human vector of Yellow Fever Virus, the Aedes aegypti mosquito. Wolbachia has been shown to be effective in preventing transmission of other RNA Flaviviridae diseases such as Zika Virus, Dengue Fever and Chikungunya. Due to the cost-effectiveness and ease of implementing Wolbachia infections into Aedes aegypti populations it is a recommended control effort against Yellow Fever Virus transmission.
